FDA's 'Breakthrough' Label: Unpacking the Evolution of Medical Device Regulation and the Role of AI
Original framing: “STAT+: FDA’s evolving view of what makes a ‘breakthrough’ device” — STAT News
The development of medical device regulation has a long and complex history, shaped by factors such as technological innovation, economic interests, and social and cultural norms. Understanding this historical context is essential for appreciating the FDA's evolving view of 'breakthrough' devices.
The FDA's evolving view of 'breakthrough' devices reflects a broader shift towards incorporating AI and machine learning into medical device regulation.
However, this shift also raises concerns about the potential for bias and unequal access to these technologies. To address these concerns, we must develop and implement more inclusive and culturally sensitive regulatory approaches, prioritize culturally sensitive design, build the capacity of healthcare professionals and industry stakeholders, and engage in participatory research and development processes that involve marginalized communities. By taking these steps, we can create AI-powered medical devices that promote health equity and cultural sensitivity, and ensure that these technologies are developed and used in ways that benefit all members of society.